Big Earnings Dominate Headline, Meta, Google Face Political & Regulatory Pressure Over AI Expansion & More

by [Lekha Gupta] • [  • ]

Top 3 Real Estate Stocks That May Implode This Quarter

by [Avi Kapoor] • [  • ]

Jim Cramer Sees These ‘Non-Magnificent’ Tech Stocks Emerging as Market Leaders

by [Namrata Sen] • [  • ]

Tower Semiconductor CEO Says the Company’s Biggest Growth Phase Has Arrived

by [Anusuya Lahiri] • [  • ]

Twilio’s Biggest Business Is Slowing, and That’s a Problem for Its Growth Story

by [Akanksha Bakshi] • [  • ]

Top 3 Real Estate Stocks That May Implode This Quarter

As of Nov. 6, 2026, three stocks in the real estate sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicato[...]

by [Avi Kapoor] • [  • ]

Jim Cramer Sees These ‘Non-Magnificent’ Tech Stocks Emerging as Market Leaders

CNBC’s Jim Cramer said that technology leadership may be broadening beyond the Magnificent Seven stocks, as semiconductor and networking stocks regained momentum. On Tuesday, Cramer said on “Mad[...]

by [Namrata Sen] • [  • ]

Tower Semiconductor CEO Says the Company’s Biggest Growth Phase Has Arrived

Tower Semiconductor Ltd. (NASDAQ:TSEM) stock traded higher in Monday’s premarket session after the Israeli chipmaker reported record third-quarter 2026 results that beat Wall Street estimates and issu[...]

by [Anusuya Lahiri] • [  • ]

Twilio’s Biggest Business Is Slowing, and That’s a Problem for Its Growth Story

Twilio Inc. (NYSE:TWLO) stock plunged in premarket trading Friday as slowing growth in its largest business and a softer fourth-quarter outlook overshadowed better-than-expected earnings, record reven[...]

by [Akanksha Bakshi] • [  • ]

Eli Lilly Says Retatrutide Delivers More Than Double Ozempic’s Weight Loss in Late-Stage Diabetes Trial

Eli Lilly and Company (NYSE: LLY) said its investigational drug retatrutide delivered “more than double the weight loss of the highest approved dose of Ozempic,” from Novo Nordisk A/S (NYS[...]

by [Tanya Rawat] • [  • ]

Moderna Stock Saga: Leaked Data, a Panicked Influencer and Perfect Timing

Moderna Inc. (NASDAQ:MRNA) investors spent months treating the company’s cancer vaccine as a potential cure. Last week, leaked trial data delivered a reality check. The stock plunged roughly 26% intra[...]

by [Erica Kollmann] • [  • ]

Why Is Moderna Stock Sinking Thursday?

Moderna Inc. (NASDAQ:MRNA) stock plunged more than 25% Thursday after the alleged leak of an ESMO 2026 conference abstract raised concerns about the effectiveness of its experimental personalized mela[...]

by [Vandana Singh] • [  • ]

NEWSLETTER